Literature DB >> 9329412

Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism.

H M Janssens1, M J de Haan, I L van Kamp, R Brand, H H Kanhai, S Veen.   

Abstract

OBJECTIVE: To describe the outcome for 92 fetuses treated between May 1987 and January of 1993 with intrauterine (intravascular) transfusions for severe hemolytic disease in comparison with a high-risk and a healthy control group. STUDY
DESIGN: Information on the perinatal period was obtained from the patient records. The children regularly attended the outpatient clinic, and a general pediatric examination was performed on each visit. The psychometer development of the child until age 4 1/2 years was assessed according to Gesell. At the age of 5 years, the adaptation part of the Denver Developmental Screening Test and a Dutch-language test were used. A neurologic examination was performed according to Touwen.
RESULTS: In our study, 77 (83.7%) of 92 fetuses were born alive after intravascular transfusions. The overall survival rate was 79.3%. The follow-up group included 69 infants, with an age range of 6 months to 6 years. Correlation between antenatal and perinatal features showed a significant negative relationship between the number of intrauterine transfusions and the duration of phototherapy (p = 0.002). The probability that neurologic abnormalities would occur was significantly greater when perinatal asphyxia had been present (p < 0.05) and with a lower cord hemoglobin level at birth (p = 0.03). The total number of children with disabilities was 10.1% (7/69).
CONCLUSIONS: The neurodevelopmental outcome for the group of survivors compared favorably with a group of high-risk, very low birth weight infants (10.1% to 18%), and less favorably with a healthy control group (10.1% to 6%).

Entities:  

Mesh:

Year:  1997        PMID: 9329412     DOI: 10.1016/s0022-3476(97)80061-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells.

Authors:  Beate Mayer; Larry Hinkson; Wiebke Hillebrand; Wolfgang Henrich; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2018-10-31       Impact factor: 3.747

2.  Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.

Authors:  Esther P Verduin; Irene T M Lindenburg; Vivianne E H J Smits-Wintjens; Jeanine M M van Klink; Henk Schonewille; Inge L van Kamp; Dick Oepkes; Frans J Walther; Humphrey H H Kanhai; Ilias I N Doxiadis; Enrico Lopriore; Anneke Brand
Journal:  BMC Pregnancy Childbirth       Date:  2010-12-01       Impact factor: 3.007

3.  Successful intrauterine treatment and good long-term outcome in an extremely severe case of fetal hemolytic disease.

Authors:  Marzena Dębska; Piotr Kretowicz; Anna Tarasiuk; Joanna Dangel; Romuald Dębski
Journal:  J Ultrason       Date:  2014-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.